1. Home
  2. LEGH vs SGMT Comparison

LEGH vs SGMT Comparison

Compare LEGH & SGMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Legacy Housing Corporation (TX)

LEGH

Legacy Housing Corporation (TX)

N/A

Current Price

$29.24

Market Cap

691.6M

ML Signal

N/A

Logo Sagimet Biosciences Inc. Series A

SGMT

Sagimet Biosciences Inc. Series A

N/A

Current Price

$9.85

Market Cap

761.6M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
LEGH
SGMT
Founded
2005
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
691.6M
761.6M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
LEGH
SGMT
Price
$29.24
$9.85
Analyst Decision
Buy
Buy
Analyst Count
2
12
Target Price
★ $28.00
$27.91
AVG Volume (30 Days)
75.6K
★ 1.2M
Earning Date
11-04-2026
11-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ 2.29
N/A
Revenue
★ $164,567,000.00
$2,000,000.00
Revenue This Year
$23.39
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$13.88
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$18.29
$4.50
52 Week High
$32.89
$11.45

Technical Indicators

Market Signals
Indicator
LEGH
SGMT
Relative Strength Index (RSI) 52.26 50.81
Support Level $25.07 $6.44
Resistance Level $30.36 $11.23
Average True Range (ATR) 1.78 0.65
MACD 0.22 0.01
Stochastic Oscillator 25.16 42.11

Price Performance

Historical Comparison
LEGH
SGMT

About LEGH Legacy Housing Corporation (TX)

Legacy Housing Corp builds, sells, and finances manufactured homes and tiny houses that are distributed through a network of independent retailers and company-owned stores, and are also sold directly to manufactured home communities. The Company manufactures and provides for the transport of manufactured homes, provides wholesale financing to dealers and mobile home parks, provides retail financing to consumers, and is involved in financing and developing new manufactured home communities. The Company manufactures its mobile homes at plants in Fort Worth, Texas; Commerce, Texas; and Eatonton, Georgia. The Company also sells homes directly to consumers, through its own retail stores, and to dealers and mobile home parks.

About SGMT Sagimet Biosciences Inc. Series A

Sagimet Biosciences Inc a clinical-stage biopharmaceutical company developing novel therapeutics called fatty acid synthase (FASN) inhibitors that target dysfunctional metabolic and fibrotic pathways in diseases resulting from the overproduction of the fatty acid, palmitate. Its drug candidate, denifanstat, is an oral, once-daily pill and selective FASN inhibitor in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), acne and select forms of cancer. Its second FASN inhibitor, TVB-3567, is a potent and selective small molecule FASN inhibitor in development for acne. It operates as a single business segment, developing and commercializing therapeutics for the treatment of MASH and other diseases where FASN plays a pathogenic role.

Share on Social Networks: